Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Cleveland Clinic Journal of Medicine|September 2, 2008
Take charge of your e-mail!Neil B Mehta, Ashish Atreja, Anil Jain
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
Development and psychometric validation of a brief instrument to measure satisfaction with online trainingMichel Avital, Ashish Atreja, Neil Mehta, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Using Web 2.0 technologies to develop a resource for evidence based medicineAshish Atreja, B Messinger-Rapport, Anil Jain, et al.
Annals of Internal Medicine|February 3, 2005
Responding to the rofecoxib withdrawal crisis: a new model for notifying patients at risk and their health care providersAnil Jain, Ashish Atreja, C Martin Harris, et al.
BMC Medical Education|October 17, 2008
Satisfaction with web-based training in an integrated healthcare delivery network: do age, education, computer skills and attitudes matter?Ashish Atreja, Neil B Mehta, Anil K Jain, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 10, 2007
Repeat dual-energy X-ray absorptiometry (DXA) resulting from reminder letters for women with a baseline abnormal DXALaura Shoemaker, Andrea Sikon, Anil Jain, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 17, 2006
Drug-age alerting for outpatient geriatric prescriptions: a joint study using interoperable drug standardsAshish Atreja, Michael Buck, Anil Jain, et al.
International Review of Psychiatry (Abingdon, England)|March 25, 2015
Online social support networksNeil Mehta, Ashish Atreja
Diabetes Care|March 11, 2010
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysisKevin M Pantalone, Michael W Kattan, Changhong Yu, et al.
Acta Diabetologica|February 6, 2009
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysisKevin M Pantalone, Michael W Kattan, Changhong Yu, et al.
Pageof 17